Modulation of Cellular, Molecular, and Humoral Responses by PQ Grass 27,600 SU for the Treatment of Seasonal Allergic Rhinitis: A Randomised Double Blind Placebo Control Exploratory Field Study
Allergy2025Vol. 81(1), pp. 232–247
Janice A. Layhadi, Sviatlana Starchenka, Pieter‐Jan de Kam, Elizabeth Palmer, Lily Y.D. Wu, Sean T. Keane, William T. Fulton, Prista Hikmawati, Xun Meng, Paulina Filipaviciute, Anna Cutrina Pons, Kemi Oluwayi, Katarzyna Lis, Oliver Armfield, Murray Skinner, Matthew D. Heath, Simon Hewings, Matthias Krämer, Mohamed H. Shamji
Abstract
Trial number: PQGrass309, EudraCT number: 2020-000408-13, Clinicaltrials.gov identifier: NCT04687059, and NCT05540717.
Related Papers
- → Positive reactions to placebo in children undergoing double‐blind, placebo‐controlled food challenge(2014)28 cited
- → Soy in hypercholesterolaemia: a double-blind, placebo-controlled trial(2002)55 cited
- → Domperidone in the Treatment of Dyspepsia: A Double-Blind Placebo-Controlled Study(1979)27 cited
- → Schizophrenia: Do we really need placebo-controlled studies?(1998)20 cited
- → “A wolf in sheep's clothing”: when so‐called placebo interventions are not what they seem(2023)1 cited